Supplements Exposed: What Really Works for Prostate Health

DrTalks

G. Espinosa

Prostate Cancer Diagnosis Pathway: 2024 Update

Anwar Padhani

A. Padhani

Year in Review: Prostate Cancer - 2024 Insights and Exciting Prospec…

Jason Hafron

Prostate Cancer Ablation - The Best Option For Your Intermediate Ris…

Preston Sprenkle

Year in Review - Prostate Cancer

Oncology 2024 Year in Review

K. Tawagi

Prostate Cancer Detection: MRI, Image Quality, and PI-RADS Techniques

International Cancer Imaging Society (ICIS)

P. Asbach

Year in Review 2024 - Managing Advanced Prostate Cancer

Oncology 2024 Year in Review

R. Dreicer

Robot-assisted Radical Prostatectomy (RARP)

Bernardo Rocco

Year in Review - Key Clinical Trials in Prostate Cancer

GWU Urology

HoLEP in a Patient in Urinary Retention With Metastatic Prostate Can…

Pieter Uvin

Year in Review: Cutting Edge Advances in Kidney Cancer - Imaging and…

Ketan Badani

Bladder Cancer Highlights From ASCO® 2024

2024 ASCO® Annual Meeting Insights Hub

G. Sonpavde

Ideal Treatment Sequence After ADT + ARPI + Docetaxel for mHSPC

Advanced Prostate Cancer Consensus Conference (APCCC)

K. Fizazi

Cancer Screening in Primary Care: An Evidence-Based Review of Outpat…

UNC Lineberger Comprehensive Cancer Center

N. Robertson

Enhanced Diagnostics in Prostate Cancer: PSA and Beyond in 2024

Penn Medicine Abramson Cancer Center

D. Lee

Year in Review 2024 - Bladder Cancer

Oncology 2024 Year in Review

G. Sonpavde

Surgical Management of High-Risk and Locally Advanced Prostate Cancer

Yale Cancer Center

I. Kim

ASCO® GU 2025 Summary: Perioperative Strategies in MIBC - Key Trial …

Insights from 2025 ASCO® GU Annual Meeting

E. Plimack

Practical Considerations for PSMA-Targeted Therapy in Prostate Cancer

University of Illinois Cancer Center

K. Tawagi, N. Reizine

My Journey to Partial Gland Ablation of Prostate Cancer

Focal Therapy Society

H. Lepor